In the past ten years, NuvaRing has become a popular birth control alternative for women who want more protection than that offered by traditional pills but don’t want to commit to the cost or implant procedure of an IUD.
Unfortunately for the millions of women who have used the devices, they have now been associated with blood clot risks, just like third and fourth-generation pill contraceptives.
In 2012, the New England Journal of Medicine and British Medical Journal both published research which concluded vaginal ring contraceptives like NuvaRing were related to a 2 to 3-times increased risk of blood clots over traditional pills.
Blood clots can cause dangerous conditions like stroke, DVT and pulmonary embolism.
Although Merck claims that NuvaRing uses lower hormone doses, experts have proposed that the constant and direct absorption of the chemicals into the bloodstream can result in higher overall doses for some women.
As of January, more than 1,000 patients had filed a NuvaRing lawsuit in a special federal court in Missouri. Other cases are awaiting trial in New Jersey state court, where Merck is headquartered. Cases have grown by approximately 2% in recent months.
Judge Sippel, who is overseeing the federal case, has scheduled trials to begin this summer.
Those injured by NuvaRing side effects still have time to file a claim. If you or a loved one suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing, it is important to speak with a lawyer about your legal rights as soon as possible.
Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer, contact us today.